Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The FDA's evaluation of GLP-1 receptor agonists has not identified colon cancer as a confirmed risk associated with this drug class
Further, many employers (as high as 59% of employers with at least 5,000 workers) that offered such coverage said that use of GLP-1 medications was higher than expected, and 66% of the largest employers said that covering such drugs for weight loss had a significant impact on their health plans prescription drug spending
Thank you so much!" David H
Narita T, Katsuura Y, Sato T, Hosoba M, Fujita H, Morii T, Yamada Y
Ozempic is approved for adults with type 2 diabetes at a target weekly dose of 1.0mg or 2.0mg
The adjusted difference in mean SBP (mm Hg) change between groups was 5.9 mm Hg (95% CI 12.0 to 0.2, P = 0.059)
